Citations (65)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (15)
Reynold Panettieri Jr, Njira Lugogo, Jonathan Corren & Christopher S Ambrose. (2024) Tezepelumab for Severe Asthma: One Drug Targeting Multiple Disease Pathways and Patient Types. Journal of Asthma and Allergy 17, pages 219-236.
Read now
Read now
Fanny Wai-San Ko, Julie KL Wang, David SC Hui, Johnny WM Chan, Pik-Shan Cheung, Yiu-Cheong Yeung, Kit Man Sin & Mary Sau-Man Ip. (2023) A Multi-Center Study of the Prevalence and Characteristics of Eosinophilic Phenotype and High IgE Levels Among Chinese Patients with Severe Asthma. Journal of Asthma and Allergy 16, pages 173-182.
Read now
Read now
J. Michael Ramsahai, Arsh Randhawa, Cal Shephard, Andrew Foster, Lee Geyer, Phong Manivong, Erin Graves & Suzanne McMullen. (2023) A population-based study of the burden of severe asthma in Alberta, Canada. Canadian Journal of Respiratory, Critical Care, and Sleep Medicine 7:4, pages 192-200.
Read now
Read now
Fraence Hardtstock, Julia Krieger, Thomas Wilke, Marco Lukas, Bernhard Ultsch, Robert Welte, Renate Quinzler, Ulf Maywald & Hartmut Timmermann. (2023) Epidemiology, treatment and health care resource use of patients with severe asthma in Germany – a retrospective claims data analysis. Journal of Asthma 60:7, pages 1280-1289.
Read now
Read now
M. Mareque, M. Climente, E. Martinez-Moragon, A. Padilla, I. Oyagüez, C. Touron, C. Torres & A. Martinez. (2023) Cost-effectiveness of benralizumab versus mepolizumab and dupilumab in patients with severe uncontrolled eosinophilic asthma in Spain. Journal of Asthma 60:6, pages 1210-1220.
Read now
Read now
Peter A. B. Wark, Mark Hew, Yang Xu, Clare Ghisla, Tra-My Nguyen, Bora Erdemli, Aditya Samant & Cassandra Nan. (2023) Regional variation in prevalence of difficult-to-treat asthma and oral corticosteroid use for patients in Australia: heat map analysis. Journal of Asthma 60:4, pages 727-736.
Read now
Read now
Muthu Thiruvengadam, Umadevi Subramanian, Baskar Venkidasamy, Prabhu Thirupathi, Ramkumar Samynathan, Mohammad Ali Shariati, Maksim Rebezov, Ill-Min Chung & Kannan R. R. Rengasamy. (2023) Emerging role of nutritional short-chain fatty acids (SCFAs) against cancer via modulation of hematopoiesis. Critical Reviews in Food Science and Nutrition 63:6, pages 827-844.
Read now
Read now
Fraence Hardtstock, Julia Krieger, Thomas Wilke, Marco Lukas, Bernhard Ultsch, Robert Welte, Renate Quinzler, Ulf Maywald & Hartmut Timmermann. (2022) Use of Biologic Therapies in the Treatment of Asthma – A Comparative Real World Data Analysis on Healthcare Resource Utilization and Costs Before and After Therapy Initiation. Journal of Asthma and Allergy 15, pages 407-418.
Read now
Read now
Jane R Parnes, Nestor A Molfino, Gene Colice, Ubaldo Martin, Jonathan Corren & Andrew Menzies-Gow. (2022) Targeting TSLP in Asthma. Journal of Asthma and Allergy 15, pages 749-765.
Read now
Read now
Magnus Nilsson, Magdalena Rhedin, Ramon Hendrickx, Susanne Berglund, Antonio Piras, Parmis Blomgran, Anders Cavallin, Mia Collins, Göran Dahl, Bilel Dekkak, Therese Ericsson, Niklas Hagberg, Ann Aurell Holmberg, Agnes Leffler, Anders J Lundqvist, Thomais Markou, James Pinkerton, Lars Rönnblom, Stacey Siu, Vanessa Taylor, Tiiu Wennberg, Dimitrios Zervas, Arian D J Laurence, Suman Mitra, Maria G Belvisi, Mark Birrell & Annika Borde. (2022) Characterization of Selective and Potent JAK1 Inhibitors Intended for the Inhaled Treatment of Asthma. Drug Design, Development and Therapy 16, pages 2901-2917.
Read now
Read now
Andrew Menzies-Gow, Jason Steenkamp, Sumeet Singh, Wilma Erhardt, Jennifer Rowell, Pallavi Rane, Neil Martin, Jean Pierre Llanos & Anna Quinton. (2022) Tezepelumab compared with other biologics for the treatment of severe asthma: a systematic review and indirect treatment comparison. Journal of Medical Economics 25:1, pages 679-690.
Read now
Read now
Arnaud Bourdin, Dominick Shaw, Andrew Menzies-Gow, J. Mark FitzGerald, Eugene R. Bleecker, William W. Busse, Gary T. Ferguson, Laura Brooks, Peter Barker, Esther Garcia Gil & Ubaldo J. Martin. (2021) Two-year integrated steroid-sparing analysis and safety of benralizumab for severe asthma. Journal of Asthma 58:4, pages 514-522.
Read now
Read now
A. Viinanen, M. I. Lassenius, I. Toppila, A. Karlsson, L. Veijalainen, J. J. Idänpään-Heikkilä & T. Laitinen. (2020) The burden of adult asthma in Finland: impact of disease severity and eosinophil count on health care resource utilization. Journal of Asthma 57:10, pages 1092-1102.
Read now
Read now
Gail M. Gauvreau, Roma Sehmi, Christopher S. Ambrose & Janet M. Griffiths. (2020) Thymic stromal lymphopoietin: its role and potential as a therapeutic target in asthma. Expert Opinion on Therapeutic Targets 24:8, pages 777-792.
Read now
Read now
Marco Caminati, Brooke Polk & Lanny J. Rosenwasser. (2019) What have recent advances in therapy taught us about severe asthma disease mechanisms?. Expert Review of Clinical Immunology 15:11, pages 1145-1153.
Read now
Read now
Articles from other publishers (50)
Paola Maria Cutroneo, Elena Arzenton, Fabiana Furci, Fabio Scapini, Maria Bulzomì, Nicoletta Luxi, Marco Caminati, Gianenrico Senna, Ugo Moretti & Gianluca Trifirò. (2024) Safety of Biological Therapies for Severe Asthma: An Analysis of Suspected Adverse Reactions Reported in the WHO Pharmacovigilance Database. BioDrugs 38:3, pages 425-448.
Crossref
Crossref
Christos Kyriakopoulos, Athena Gogali, Georgios Markozannes & Konstantinos Kostikas. (2024) Biologic agents licensed for severe asthma: a systematic review and meta-analysis of randomised controlled trials. European Respiratory Review 33:172, pages 230238.
Crossref
Crossref
Richard J. Russell, Louis-Philippe Boulet, Christopher E. Brightling, Ian D. Pavord, Celeste Porsbjerg, Del Dorscheid & Asger Sverrild. (2024) The airway epithelium: an orchestrator of inflammation, a key structural barrier and a therapeutic target in severe asthma. European Respiratory Journal 63:4, pages 2301397.
Crossref
Crossref
Tara Carr, Joseph Tkacz, Yen Chung, Christopher S. Ambrose, Joseph Spahn, Pallavi Rane, Yan Wang, Andrew W. Lindsley, Benjamin Lewing & Autumn Burnette. (2024) Gaps in Care Among Uncontrolled Severe Asthma Patients in the United States. The Journal of Allergy and Clinical Immunology: In Practice.
Crossref
Crossref
Laurent Guilleminault, Michael Mounié, Agnès Sommet, Claire Camus, Alain Didier, Laurent Lionel Reber, Cécile Conte & Nadège Costa. (2024) The economic burden of asthma prior to death: a nationwide descriptive study. Frontiers in Public Health 12.
Crossref
Crossref
Ianthe R.M. Schepel, Tina M. Banzon & Wanda Phipatanakul. (2024) Future of biologics in pediatric asthma. Annals of Allergy, Asthma & Immunology 132:1, pages 13-20.
Crossref
Crossref
Gabriel Lavoie & Ian D. Pavord. (2023) Which biologic? New findings from a real‐world study. Respirology 28:12, pages 1091-1092.
Crossref
Crossref
Xiao XuCaroline SchaeferAgota SzendeEduardo GenofreRohit KatialYen Chung. (2023) A cost comparison of benralizumab, mepolizumab, and dupilumab in patients with severe asthma: A US third-party payer perspective. Journal of Managed Care & Specialty Pharmacy 29:11, pages 1193-1204.
Crossref
Crossref
Manon Belhassen, Maeva Nolin, Flore Jacoud, Claire Marant Micallef & Eric Van Ganse. (2023) Trajectories of Controller Therapy Use Before and After Asthma-Related Hospitalization in Children and Adults: Population-Based Retrospective Cohort Study. JMIR Public Health and Surveillance 9, pages e50085.
Crossref
Crossref
Jennifer Taylor. (2023) Transforming Care in Asthma and Chronic Obstructive Pulmonary Disease: An Expert View. EMJ Respiratory, pages 2-7.
Crossref
Crossref
Andrew Menzies-Gow, Arnaud Bourdin, Geoffrey Chupp, Elliot Israel, Åsa Hellqvist, Gillian Hunter, Stephanie L. Roseti, Christopher S. Ambrose, Jean-Pierre Llanos, Bill Cook, Jonathan Corren & Gene Colice. (2023) Effect of tezepelumab on healthcare utilization in patients with severe, uncontrolled asthma. Annals of Allergy, Asthma & Immunology 131:3, pages 343-348.e2.
Crossref
Crossref
Bilal Malik, Nathan W. Bartlett, John W. Upham, Kristy S. Nichol, John Harrington & Peter A. B. Wark. (2023)
Severe asthma
ILC2s
demonstrate enhanced proliferation that is modified by biologics
. Respirology 28:8, pages 758-766.
Crossref
Crossref
Autumn BurnetteYan WangPallavi B RaneYen ChungNicole PrincicJulie ParkJean-Pierre LlanosAndrew W LindsleyChristopher S Ambrose. (2023) Incremental cost burden among patients with severe uncontrolled asthma in the United States. Journal of Managed Care & Specialty Pharmacy 29:7, pages 825-834.
Crossref
Crossref
Renaud Louis, Tim W. Harrison, Pascal Chanez, Francesco Menzella, George Philteos, Borja G. Cosio, Njira L. Lugogo, Gustavo de Luiz, Annie Burden, Timothy Adlington, Nanna Keeling, Justin Kwiatek, Esther Garcia Gil, Wolfgang Pohl, Daniel Doberer, Jean Benoit Martinot, Maud Deschampheleire, Ulrike Himpe, Kenneth Chapman, Amarjit Cheema, Delbert Dorscheid, Clare Ramsey, Jeffrey Rolf, Brandie Walker, Ronald Olivenstein, Claude Poirier, Pierre Larivee, Anne Sofie Bjerrum, Ingrid Titlestad, Ole Hilberg, Maritta Kilpeläinen, Philippe Bonniaud, Camille Taillé, Iuliana-Angelica Tiotiu, Pierre-Olivier Girodet, François-Xavier Blanc, Johana Pradelli, Alain Didier, Cecilia Nocent Ejnaini, Gaetan Deslee, Christophe Pison, Youcef Douadi, Guillaume Mahay, Gilles Devouassoux, Boris Melloni, Pauline-Marie Roux, Arnaud Bourdin, Stephanie Fry, Thomas Schaum, Christian Schulz, Dirk Skowasch, Christian Taube, Tobias Welte, Wolfgang Gleiber, Randolf Brehler, Jens Schreiber, Wolfgang Schuette, Juliane Kronsbein, Reiner Bonnet, Ekkehard Beck, Donato Lacedonia, Gianenrico Senna, Cristiano Caruso, Nunzio Crimi, Francesco Blasi, Pierachille Santus, Giorgio Walter Canonica, Gabriella Guarnieri, Girolamo Pelaia, Manlio Milanese, Claudio Micheletto, Angelo Guido Corsico, Nicola Scichilone, Giuseppe Spadaro, Bas Langeveld, Jurgen Holters, Jan Willem van den Berg, Arthur Smit, Lennart Conemans, Helena van Veen, Gerald Staaks, Sverre Lehmann, Jose Maria Echave-Sustaeta, Christian Domingo Ribas, Gustavo de Luiz Martinez, Ruperto Gonzalez Perez, Juan Luis Garcia Rivero, Xavier Muñoz Gall, Jose Gregorio Soto Campos, Paloma Campo Mozo, Carmen Vidal Pan, Ana Gomez-Bastero Fernandez, Sergio Campos Tellez, Carlos Martinez Rivera, Irina Diana Bobolea, Raquel Morillo Guerrero, Ismael Ali Garcia, Juan Luis Rodriguez Hermosa, Nikolai Stenfors, Alf Tunsäter, Dan Curiac, Christophe von Garnier, Joerg Leuppi, Peter Schmid-Grendelmeier, Shuaib Nasser, Rekha Chaudhuri, Monica Nordstrom, Dinesh Saralaya, Paul Pfeffer, Adel Mansur, Philip Short, Sally Wenzel, William Brett Cherry, Heidi Zafra, Erika Gonzalez, Weily Soong, Benjamin Davis, Neil Kao, Iftikhar Hussain, Diego Jose Maselli Caceres, James Harris, William Calhoun, Ileana Rodicio, David Kaufman, Mark Moss, Eric Sztejman, Samuel DeLeon, Kaharu Sumino, Ravindra Kashyap, Jeffrey Leflein, Rizan Hajal, Faisal Fakih, David Hill, Robert Lin, Mikell Jarratt, Vijay Subramaniam, Robert Sussman, Nayla Mumneh, Joan Reibman, Jared Darveaux, Ricardo Tan, Tonny Tanus, Vinay Sikand, Gailen Marshall, Hemalini Mehta, Jeremy Cole, Brad Goodman, Deborah Goss, Jose Bardelas, Aaron Milstone, Vinay Mehta, Lee Clore, Mark Millard, Michael Palumbo, Dileep Puppala, Mila Leong, Bruce Prenner, Emory Robinette, Hengameh Heidarian Raissy, David Fost, Warren Pleskow, Michael Marcus, Jonathan Ilowite, Wendy Moore, Gary Steven, Luis De la Cruz, Geoffrey Chupp, William Berger, Christopher Randolph, Fernando Holguin, Shahrukh Kureishy, Edward Campbell, Rudi Peche, Laura Pini, Alberto Papi, Bianca Beghé, Silvia Peveri, Aythamy Henriquez Santa, Jacinto Ramos Gonzalez, Ines Vinge & Roy St. John. (2023) Severe Asthma Standard-of-Care Background Medication Reduction With Benralizumab: ANDHI in Practice Substudy. The Journal of Allergy and Clinical Immunology: In Practice 11:6, pages 1759-1770.e7.
Crossref
Crossref
Luke E. Barry, Ciaran O’Neill, Claire Butler, Rekha Chaudhuri & Liam G. Heaney. (2023) Cost-Effectiveness of Fractional Exhaled Nitric Oxide Suppression Testing as an Adherence Screening Tool Among Patients With Difficult-to-Control Asthma. The Journal of Allergy and Clinical Immunology: In Practice 11:6, pages 1796-1804.e3.
Crossref
Crossref
Jung-Hyun Kim, Hyesung Lee, So-Young Park, Ju-Young Kim, Sun Hee Choi, Hyouk-Soo Kwon, Woo-Jung Song, Sae-Hoon Kim, Jinho Yu, Dae Jin Song, You Sook Cho, Dae Hyun Lim, Young-Joo Cho, Suk-Il Chang & Tae-Bum Kim. (2023) Epidemiology of patients with asthma in Korea: Analysis of the NHISS database 2006–2015. World Allergy Organization Journal 16:4, pages 100768.
Crossref
Crossref
Yenealem Solomon, Birhanemaskal Malkamu, Ayenew Berhan, Tahir Eyayu, Andargachew Almaw, Biruk Legese & Berhanu Woldu. (2023) Peripheral blood eosinophilia in adult asthmatic patients and its association with the severity of asthma. BMC Pulmonary Medicine 23:1.
Crossref
Crossref
Tanawin Nopsopon, Grace Lassiter, Ming-Li Chen, G. Caleb Alexander, Corinne Keet, Hwanhee Hong & Ayobami Akenroye. (2023) Comparative efficacy of tezepelumab to mepolizumab, benralizumab, and dupilumab in eosinophilic asthma: A Bayesian network meta-analysis. Journal of Allergy and Clinical Immunology 151:3, pages 747-755.
Crossref
Crossref
Serena Casanova, Engi Ahmed & Arnaud Bourdin. 2023. Precision Approaches to Heterogeneity in Asthma. Precision Approaches to Heterogeneity in Asthma
239
252
.
Andrew Menzies-Gow, David J. Jackson, Mona Al-Ahmad, Eugene R. Bleecker, Francisco de Borja G. Cosio Piqueras, Stephen Brunton, Giorgio Walter Canonica, Charles K. N. Chan, John Haughney, Steve Holmes, Janwillem Kocks & Tonya Winders. (2022) A Renewed Charter: Key Principles to Improve Patient Care in Severe Asthma. Advances in Therapy 39:12, pages 5307-5326.
Crossref
Crossref
Chaimae Asaad & Mounir Ghogho. (2022) AsthmaKGxE: An asthma–environment interaction knowledge graph leveraging public databases and scientific literature. Computers in Biology and Medicine 148, pages 105933.
Crossref
Crossref
Janis SHUTE. (2022) Biomarkers of asthma. Minerva Medica 113:1.
Crossref
Crossref
Nam-Kyong Choi, Sumitra Shantakumar, Mi-Sook Kim, Chang-Hoon Lee, Wendy Y Cheng, Priyanka Bobbili, Bo Ram Yang, Joongyub Lee, David Hinds, Mei Sheng Duh, Caroline Korves & Heung-Woo Park. (2022) Real-world Treatment Patterns, Outcomes, and Healthcare Resource Utilization in Newly Treated Korean Patients With Asthma: A Retrospective Cohort Study. Allergy, Asthma & Immunology Research 14:2, pages 220.
Crossref
Crossref
Adil Adatia, Mustafaa Wahab & Imran Satia. (2021) Is tezepelumab more than just an anti-eosinophil drug?. European Respiratory Journal 59:1, pages 2101700.
Crossref
Crossref
Eugene R. Bleecker, Hitesh Gandhi, Ileen Gilbert, Kevin R. Murphy & Geoffrey L. Chupp. (2022) Mapping geographic variability of severe uncontrolled asthma in the United States. Annals of Allergy, Asthma & Immunology 128:1, pages 78-88.
Crossref
Crossref
Piers Dixey, Hisham Abubakar-Waziri, Katie Raby, Ramzi Lakhdar, Nazanin Kermani, Sharon Mumby, Elizabeth Owen, Ian Adcock, Pankaj Bhavsar & Kian Fan Chung. 2022. Encyclopedia of Respiratory Medicine. Encyclopedia of Respiratory Medicine
383
399
.
Shirui Cheng, Xiaohui Dong, Lei Lan, Zhaoxuan He, Siyi Yu, Yi Yang, Chuantao Zhang, Mei Chen, Jun Yang, Haoran Chu, Yalan Liu, Menglin Wang, Qingsong Huang & Fang Zeng. (2021) Acupuncture for chronic persistent asthma based on the theory of Meridian-viscera Association: study protocol for a multi-center randomized controlled trial in China. Trials 22:1.
Crossref
Crossref
Lei Guo, Lie WangZhongtian Wang, Lina WeiLizhong DingYibu KongZhimei LiuYe Tian, Fushuang Yang & Liping Sun. (2021) Evaluation of the effectiveness and safety of cupping therapy in the treatment of asthma. Medicine 100:41, pages e27518.
Crossref
Crossref
Joan Reibman, Laren Tan, Chris Ambrose, Yen Chung, Pooja Desai, Jean-Pierre Llanos, Meghan Moynihan & Joseph Tkacz. (2021) Clinical and economic burden of severe asthma among US patients treated with biologic therapies. Annals of Allergy, Asthma & Immunology 127:3, pages 318-325.e2.
Crossref
Crossref
Carlos E. Rodriguez‐Martinez, Monica P. Sossa‐Briceño & Jose A. Castro‐Rodriguez. (2021) Cost‐utility of omalizumab for the treatment of uncontrolled moderate‐to‐severe persistent pediatric allergic asthma in a middle‐income country. Pediatric Pulmonology 56:9, pages 2987-2996.
Crossref
Crossref
Andrew Menzies-GowJonathan CorrenArnaud BourdinGeoffrey ChuppElliot IsraelMichael E. WechslerChristopher E. BrightlingJanet M. GriffithsÅsa HellqvistKarin BowenPrimal KaurGun AlmqvistSandhia PonnarambilGene Colice. (2021) Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma. New England Journal of Medicine 384:19, pages 1800-1809.
Crossref
Crossref
Chunxia Zhang, Qian Qin & Hongle Li. (2021) Targeted Therapeutic Effect of Bavachinin Nanospheres on Pathological Site of Chronic Asthmatic Mice Model. Journal of Nanoscience and Nanotechnology 21:2, pages 1085-1090.
Crossref
Crossref
Mi-Ae Kim, Heung-Woo Park, Byung-Keun Kim, So-Young Park, Ga-Young Ban, Ji-Hyang Lee, Jin An, Ji-Su Shim, Youngsoo Lee, Ha-Kyeong Won, Hwa Young Lee, Kyoung-Hee Sohn, Sung-Yoon Kang, So Young Park, Hyun Lee, Min-Hye Kim, Jae-Woo Kwon, Sun-Young Yoon, Jae-Hyun Lee, Chin Kook Rhee, Ji-Yong Moon, Taehoon Lee, So Ri Kim, Jong Sook Park, Sang-Heon Kim, Jae Won Jeong, Sang-Hoon Kim, Young-Il Koh, Yeon-Mok Oh, An-Soo Jang, Kwang Ha Yoo & You Sook Cho. (2021) Specialist Perception of Severe Asthma in Korea: A Questionnaire Survey. Allergy, Asthma & Immunology Research 13:3, pages 507.
Crossref
Crossref
Ioana Agache, Cezmi A. Akdis, Mubeccel Akdis, Giorgio Walter Canonica, Thomas Casale, Tomas Chivato, Jonathan Corren, Derek K. Chu, Stefano Del Giacco, Thomas Eiwegger, Breda Flood, Davide Firinu, James E. Gern, Eckard Hamelmann, Nicola Hanania, Irene Hernández‐Martín, Rebeca Knibb, Mika Mäkelä, Parameswaran Nair, Liam O’Mahony, Nikolaos G. Papadopoulos, Alberto Papi, Hae‐Sim Park, Luis Pérez de Llano, Oliver Pfaar, Santiago Quirce, Joaquin Sastre, Mohamed Shamji, Jurgen Schwarze, Oscar Palomares & Marek Jutel. (2020) EAACI Biologicals Guidelines—Recommendations for severe asthma. Allergy 76:1, pages 14-44.
Crossref
Crossref
Andrew Menzies-Gow, Gene Colice, Janet M. Griffiths, Gun Almqvist, Sandhia Ponnarambil, Primal Kaur, Gennaro Ruberto, Karin Bowen, Åsa Hellqvist, May Mo & Esther Garcia Gil. (2020) NAVIGATOR: a phase 3 multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy and safety of tezepelumab in adults and adolescents with severe, uncontrolled asthma. Respiratory Research 21:1.
Crossref
Crossref
Andrew Menzies-Gow, Michael E. Wechsler & Chris E. Brightling. (2020) Unmet need in severe, uncontrolled asthma: can anti-TSLP therapy with tezepelumab provide a valuable new treatment option?. Respiratory Research 21:1.
Crossref
Crossref
Maho Suzukawa, Nobuharu Ohshima, Hiroyuki Tashimo, Isao Asari, Nobuyuki Kobayashi, Shunsuke Shoji, Shigeto Tohma & Ken Ohta. (2020) A Low Serum CCL4/MIP-1β Level May Predict a Severe Asthmatic Responsiveness to Mepolizumab. Internal Medicine 59:22, pages 2849-2855.
Crossref
Crossref
Marco Caminati, Diego Bagnasco, Lanny J. Rosenwasser, Andrea Vianello & Gianenrico Senna. (2020) Biologics for the Treatments of Allergic Conditions. Immunology and Allergy Clinics of North America 40:4, pages 549-564.
Crossref
Crossref
Luke Evan Barry, Ciaran O’Neill & Liam G Heaney. (2020) Association between asthma, corticosteroids and allostatic load biomarkers: a cross-sectional study. Thorax 75:10, pages 835-841.
Crossref
Crossref
Bryce W.Q. Tan, Wei Liang Sim, Jit Kong Cheong, Win Sen Kuan, Thai Tran & Hui Fang Lim. (2020) MicroRNAs in chronic airway diseases: Clinical correlation and translational applications. Pharmacological Research 160, pages 105045.
Crossref
Crossref
Shunbo Shi, Lu Xue, Shuhui Han, Haiting Qiu, Yongbo Peng, Ping Zhao, Qing-Hua Liu & Jinhua Shen. (2020) Anti-Contractile and Anti-Inflammatory Effects of Diacerein on Isolated Mouse Airways Smooth Muscle and Mouse Asthma Model. Frontiers in Pharmacology 11.
Crossref
Crossref
Jonathan Corren, Stephanie Chen, Luke Callan & Esther Garcia Gil. (2020) The effect of tezepelumab on hospitalizations and emergency department visits in patients with severe asthma. Annals of Allergy, Asthma & Immunology 125:2, pages 211-214.
Crossref
Crossref
Jing Pan, Qianyuan Yang, Yao Zhou, Huan Deng, Yifan Zhu, Deyu Zhao & Feng Liu. (2020) MicroRNA-221 Modulates Airway Remodeling via the PI3K/AKT Pathway in OVA-Induced Chronic Murine Asthma. Frontiers in Cell and Developmental Biology 8.
Crossref
Crossref
Ioana Agache, Yang Song, Claudio Rocha, Jessica Beltran, Margarita Posso, Corinna Steiner, Pablo Alonso‐Coello, Cezmi Akdis, Mubeccel Akdis, Giorgio Walter Canonica, Thomas Casale, Tomas Chivato, Jonathan Corren, Stefano del Giacco, Thomas Eiwegger, Davide Firinu, James E. Gern, Eckard Hamelmann, Nicola Hanania, Mika Mäkelä, Irene Hernández Martín, Parameswaran Nair, Liam O'Mahony, Nikolaos G. Papadopoulos, Alberto Papi, Hae‐Sim Park, Luis Pérez de Llano, Santiago Quirce, Joaquin Sastre, Mohamed Shamji, Jurgen Schwarze, Carlos Canelo‐Aybar, Oscar Palomares & Marek Jutel. (2020) Efficacy and safety of treatment with dupilumab for severe asthma: A systematic review of the EAACI guidelines—Recommendations on the use of biologicals in severe asthma. Allergy 75:5, pages 1058-1068.
Crossref
Crossref
Kirk Geale, Hatef Darabi, Maria Lindh, Hanna Fues Wahl, Oskar Ström, Hui Cao, Luisa Alvares, Rikke Dodge, Emil Loefroth, Alan Altraja, Vibeke Backer, Helena Backman, Leif Bjermer, Apostolos Bossios, Bernt Bøgvald Aarli, Barbro Dahlén, Ole Hilberg, Christer Janson, Hannu Kankaanranta, Jussi Karjalainen, Paula Kauppi, Maritta Kilpeläinen, Sverre Lehmann, Lauri Lehtimäki, Bo Lundbäck, Thomas Sandström, Charlotte Suppli Ulrik, Asger Sverrild, Arja Viinanen, Anna von Bülow, Valentyna Yasinska & Celeste Porsbjerg. (2020) NORDSTAR: paving the way for a new era in asthma research. European Respiratory Journal 55:4, pages 1902476.
Crossref
Crossref
Byung-Keun Kim, So-Young Park, Ga-Young Ban, Mi-Ae Kim, Ji-Hyang Lee, Jin An, Ji-Su Shim, Youngsoo Lee, Ha-Kyeong Won, Hwa Young Lee, Kyoung-Hee Sohn, Sung-Yoon Kang, So Young Park, Hyun Lee, Min-Hye Kim, Jae-Woo Kwon, Sun-Young Yoon, Jae-Hyun Lee, Chin Kook Rhee, Ji-Yong Moon, Taehoon Lee, So Ri Kim, Jong Sook Park, Sang-Heon Kim, Heung-Woo Park, Jae Won Jeong, Sang-Hoon Kim, Young-Il Koh, Yeon-Mok Oh, An-Soo Jang, Kwang Ha Yoo & You Sook Cho. (2020) Evaluation and Management of Difficult-to-Treat and Severe Asthma: An Expert Opinion From the Korean Academy of Asthma, Allergy and Clinical Immunology, the Working Group on Severe Asthma. Allergy, Asthma & Immunology Research 12:6, pages 910.
Crossref
Crossref
Ioana Agache. (2019) Severe asthma phenotypes and endotypes. Seminars in Immunology 46, pages 101301.
Crossref
Crossref
Richard J. Martin, Elisabeth H. Bel, Ian D. Pavord, David Price & Helen K. Reddel. (2019) Defining severe obstructive lung disease in the biologic era: an endotype-based approach. European Respiratory Journal 54:5, pages 1900108.
Crossref
Crossref
William C. AndersonIIIIII & Stanley J. Szefler. (2019) Cost-effectiveness and comparative effectiveness of biologic therapy for asthma. Annals of Allergy, Asthma & Immunology 122:4, pages 367-372.
Crossref
Crossref
Woo-Jung Song, Ji-Hyang Lee, Yewon Kang, Woo Joung Joung & Kian Fan Chung. (2019) Future Risks in Patients With Severe Asthma. Allergy, Asthma & Immunology Research 11:6, pages 763.
Crossref
Crossref